Senestech (SNES) to Post Earnings on Wednesday

Senestech (NASDAQ:SNES) is projected to announce its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Senestech to announce earnings of ($0.37) per share and revenue of $0.6020 million for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:00 PM ET.

Senestech (NASDAQ:SNES) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.31) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.02. The company had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.63 million. Senestech had a negative return on equity of 67.60% and a negative net margin of 304.22%. On average, analysts expect Senestech to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Senestech Price Performance

SNES stock opened at $1.62 on Tuesday. The company has a market capitalization of $8.59 million, a P/E ratio of -0.88 and a beta of 0.28. Senestech has a twelve month low of $1.22 and a twelve month high of $5.65. The business has a 50 day simple moving average of $1.53 and a 200-day simple moving average of $1.73. The company has a current ratio of 8.91, a quick ratio of 7.79 and a debt-to-equity ratio of 0.02.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of Senestech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, July 10th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Insider Buying and Selling at Senestech

In related news, major shareholder Glenbrook Capital Management purchased 35,000 shares of the firm’s stock in a transaction that occurred on Monday, July 20th. The stock was purchased at an average cost of $1.47 per share, with a total value of $51,450.00. Following the completion of the acquisition, the insider directly owned 1,057,824 shares in the company, valued at $1,555,001.28. This trade represents a 3.42% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. In the last quarter, insiders purchased 143,773 shares of company stock valued at $224,802. Company insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of SNES. XTX Topco Ltd acquired a new stake in shares of Senestech in the fourth quarter valued at about $54,000. Jane Street Group LLC acquired a new position in Senestech during the fourth quarter worth about $32,000. DRW Securities LLC increased its holdings in Senestech by 171.1% in the fourth quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after buying an additional 51,818 shares in the last quarter. Renaissance Technologies LLC increased its holdings in Senestech by 35.2% in the fourth quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock valued at $306,000 after buying an additional 37,165 shares in the last quarter. Finally, Millennium Management LLC acquired a new stake in shares of Senestech during the 3rd quarter valued at approximately $126,000. Institutional investors and hedge funds own 5.19% of the company’s stock.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.